Private or workplace plan
Ask whether the exact product is on the plan list, whether the stated use is covered, and what approval steps come first.
A savings card and a plan payment are not the same thing.
Coverage brief / the reason matters
Coverage after a Baltimore peptide doctor search
A health plan can pay for a medicine prescribed for one illness and refuse to pay for the very same medicine prescribed for another reason. The medicine’s name alone does not settle it.
The coverage map
Start with the use, then the plan
Medicare drug benefit
As of September 2026, Medicare drug law still shuts out medicines prescribed for weight loss.
That identical medicine may still be coverable for another accepted use, such as diabetes or lowering heart risk. The plan list and approval rules still apply.
Temporary Medicare route
As of September 2026, the Medicare GLP-1 Bridge, a short-term Medicare program for certain weight-loss medicines, charges eligible people $50 for a monthly supply of specified products, for fills between July 1, 2026 and December 31, 2027.
That $50 does not count toward the deductible or the yearly cap on what you pay in your Medicare drug plan (Part D).
Cash route
Cash can avoid a plan denial, but it also sits outside the plan. Ask whether any part of the payment counts toward a deductible before paying.
Where to check this
Your Medicare drug plan can tell you whether your medicine, taken for your reason, is covered.
The Bridge is a short-term trial run by Medicare itself, set up because the law still keeps Medicare drug plans from paying for weight-loss use. It did not change that law.
Maryland detail
Maryland’s proposed cap is for government health plans, not your pharmacy bill
As of September 28, 2026, Maryland had no active upper payment limit, meaning a cap on what certain health plans pay, for semaglutide (Ozempic).
The state drug affordability board had voted on a proposed limit of $274 per 30-day supply, with a possible start in 2027 for state and local government health plans.
That proposal did not set a patient cash price, and it did not apply to private plans or compounded products.
Read the Maryland board pageA short call can save a long appeal
- Is the exact product on the plan list?
- Is the stated medical use covered?
- Does the plan require prior approval?
- Which records must the prescriber send?
- What will the member pay after approval?
Next: read the evidence labels
Approval, compounding, and registration answer different questions.